A ERA synopsis for nephrology practice of the 2023 ESH Guidelines for the Management of Arterial Hypertension
Aldosterone synthase inhibitors in CKD (and EASi-KIDNEY’s outline design)
ERA Journal Club
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Access the article here
Speaker
Parminder Judge, United Kingdom
Panellists
Pantelis Sarafidis, Greece
Christoph Wanner, Germany
Moderator
Jennifer Lees, United Kingdom